Top compounds associated with response to VCP


Feature Type Standardized
Nominal ANOVA
mRNA Compound 23 citrate CTRPv2 pan-cancer AAC -0.073 0.03
mRNA GDC-0941 gCSI pan-cancer AAC 0.14 0.03
mRNA SU11274 CTRPv2 pan-cancer AAC -0.074 0.04
mRNA BRD-K27188169:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.04
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.068 0.04
mRNA Dasatinib CTRPv2 pan-cancer AAC -0.075 0.04
mRNA ML320 CTRPv2 pan-cancer AAC -0.073 0.04
mRNA Bosutinib FIMM pan-cancer AAC -0.92 0.04
mRNA Methotrexate GDSC1000 pan-cancer AAC -0.058 0.04
mRNA VER-155008 CTRPv2 pan-cancer AAC -0.074 0.04
Download CSV